Skip to main content
Clinical Trials/NCT01470508
NCT01470508
Completed
Not Applicable

Engaging Latino Families in Eating Disorders Treatment

Mae Lynn Reyes-Rodriguez, PhD2 sites in 1 country25 target enrollmentAugust 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bulimia Nervosa
Sponsor
Mae Lynn Reyes-Rodriguez, PhD
Enrollment
25
Locations
2
Primary Endpoint
Change from Baseline in Eating Disorder Examination (EDE) Scores at End of Treatment
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Promoviendo Alimentacion Saludable (PAS)"Promoting Healthy Eating" is a research project funded by the National Institute of Mental Health. The purpose of this study is to develop and test a treatment for eating disorders in Latina adults that is appropriate for their age and includes culturally appropriate family intervention.

Detailed Description

Research on culturally sensitive assessment and treatment of eating disorders among Latinos is scarce. This study is comparing individual Cognitive Behavioral Therapy (CBT) versus CBT with a family adjunctive intervention for eating disorders in Latina adults. All treatment will be conducted by trained professionals from either the UNC Eating Disorders Program (in Chapel Hill) or from El Futuro, Inc. (in Carrboro or Durham, NC) who have been trained in the treatment of eating disorders. Participants will participate in 25, 50 minute-long, face-to-face CBT sessions over 27 weeks. Participants will be randomly placed in one of two groups: CBT or CBT with family enhancement. Those participants who are randomly placed into the CBT group will participate in 25 individual therapy sessions, 3 sessions with a dietitian, and psychiatry and/or medical assessments as needed. Those participants who have been randomly placed into the CBT with family enhancement group will participate in 19 individual therapy sessions, 6 family therapy sessions, 3 sessions with a dietitian, and psychiatry and/or medical assessments as needed. All participants will also be expected to participate in baseline, week 6 (mid-treatment), end of treatment, and 3-month follow-up assessments.

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
March 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Mae Lynn Reyes-Rodriguez, PhD
Responsible Party
Sponsor Investigator
Principal Investigator

Mae Lynn Reyes-Rodriguez, PhD

Clinical Assistant Professor in Psychiatry

University of North Carolina, Chapel Hill

Eligibility Criteria

Inclusion Criteria

  • DSM-IV criteria for BN, BED, EDNOS (sub-threshold BN)
  • If taking antidepressant medication, stable dose for at least 3 months prior
  • Willingness to ask a family member or significant other to participate AND agreement of family member to participate

Exclusion Criteria

  • Any major medical condition that would interfere with treatment or require alternative treatment
  • Alcohol or drug dependence in the last three months
  • Current significant suicidal ideation
  • Developmental disability that would impair the ability of the participant to benefit from psychotherapy effectively
  • Psychosis, including schizophrenia, or bipolar I disorder
  • Pregnancy
  • Body mass index below 17.5 kg/m\^2
  • If taking antidepressant medication, doses are not stable; individuals taking any medications that can significantly affect appetite or weight.

Outcomes

Primary Outcomes

Change from Baseline in Eating Disorder Examination (EDE) Scores at End of Treatment

Time Frame: Baseline, End of Treatment

End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group.

Secondary Outcomes

  • Change from Baseline in Beck Depression Inventory-Revised (BDI-R) score at End of Treatment(Baseline, End of Treatment)
  • Change from Baseline in Beck Depression Inventory-Revised (BDI-R) score at 3 Month Follow-up(Baseline, 3 Month Follow-up)
  • Change from Baseline in Family Cohesion (FC) score at 3 Month Follow-up(Baseline, 3 Month Follow-up)
  • Change from Baseline in Family Score (FS) at 3 Month Follow-up(Baseline, 3 Month Follow-up)
  • Change from Baseline in Family Support Questionnaire score at 3 Month Follow-up(Baseline, 3 Month Followup)
  • Change from Baseline in Family Burden Interview Scale (FBIS) score at End of Treatment(Baseline, End of Treatment)
  • Treatment Adherence as of End of Treatment(Baseline, End of Treatment)
  • Change from Baseline in Eating Disorder Examination Questionnaire (EDE-Q) score at Week 6 of Treatment(Baseline, Week 6)
  • Change from Baseline in Symptom Checklist-36 (SCL-36) score at 3 Month Follow-up(Baseline, 3 Month Follow-up)
  • Change from Baseline in Family Support Questionnaire score at End of Treatment(Baseline, End of Treatment)
  • Change from Baseline in Eating Disorder Examination Questionnaire (EDE-Q) score at End of Treatment(Baseline, End of Treatment)
  • Change from Baseline in Eating Disorder Examination Questionnaire (EDE-Q) score at 3 Month Follow-up(Baseline, 3 Month Follow-up)
  • Change from Baseline in Beck Depression Inventory-Revised (BDI-R) score at Week 6 of Treatment(Baseline, Week 6)
  • Change from Baseline in the Symptom Checklist-36 (SCL-36) score at Week 6 of Treatment(Baseline, Week 6 of Treatment)
  • Change from Baseline in Symptom Checklist-36 (SCL-36) score at End of Treatment(Baseline, End of Treatment)
  • Change from Baseline in Family Cohesion (FC) score at End of Treatment(Baseline, End of Treatment)
  • Change from Baseline in Family Burden Interview Scale (FBIS) score at 3 Month Follow-up(Baseline, 3 Month Follow-up)
  • Change from Baseline in Family Score (FS) at End of Treatment(Baseline, End of Treatment)

Study Sites (2)

Loading locations...

Similar Trials